<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Cited in Smith & Nephew Osiris Acquisition Press Release

Posted by Susan Paquette on 4/8/19 10:13 AM

S&N OrisirsSmartTRAK was cited as a source in a press release from Smith & Nephew entitled "Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc."

S&N, in their presentation, announced that it has agreed to acquire Osiris Therapeutics, a fast growing company delivering regenerative medicine products, including skin, bone graft and articular cartilage substitutes, for $19.00 per share in cash, representing a total equity value of approximately $660 million, and referenced SmartTRAK Market Research as their source for Grafix and Stravix participation numbers  in the US skin substitute market, reporting that they are currently worth $900MM per annum and growing 7% annually.

SanN_In_the_news_slide_mar-14-2019

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies.  If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click the button below.

Request a Demo of the SmartTRAK  Business Intelligence Portal!

 

Topics: Advanced Wound Care

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts